EUR 1.47
(8.09%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -2.26 Million EUR | 9.51% |
2022 | -2.5 Million EUR | -167.62% |
2021 | -936.41 Thousand EUR | 52.17% |
2020 | -1.95 Million EUR | -4.19% |
2019 | -1.87 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -1.4 Million EUR | 0.0% |
2023 Q2 | -968.92 Thousand EUR | -100.0% |
2023 FY | -2.26 Million EUR | 9.51% |
2023 Q3 | -649.36 Thousand EUR | 32.98% |
2023 Q1 | -484.46 Thousand EUR | 66.04% |
2023 Q4 | -649.36 Thousand EUR | 0.0% |
2022 Q3 | -713.18 Thousand EUR | 30.21% |
2022 Q2 | -1.02 Million EUR | -100.0% |
2022 Q1 | -510.98 Thousand EUR | -11.55% |
2022 FY | -2.5 Million EUR | -167.62% |
2022 Q4 | -1.42 Million EUR | -100.0% |
2021 FY | -936.41 Thousand EUR | 52.17% |
2021 Q1 | -56.59 Thousand EUR | 85.99% |
2021 Q4 | -458.07 Thousand EUR | -100.0% |
2021 Q3 | -229.03 Thousand EUR | -102.34% |
2021 Q2 | -113.19 Thousand EUR | -100.0% |
2020 Q1 | -382.1 Thousand EUR | 0.0% |
2020 Q4 | -404.02 Thousand EUR | 0.0% |
2020 FY | -1.95 Million EUR | -4.19% |
2020 Q3 | -404.02 Thousand EUR | -5.74% |
2020 Q2 | -382.1 Thousand EUR | 0.0% |
2019 FY | -1.87 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Affluent Medical SA | -15.65 Million EUR | 85.513% |
Bluelinea Société Anonyme | -1.62 Million EUR | -39.978% |
Carmat SA | -53.86 Million EUR | 95.79% |
Diagnostic Medical Systems S.A. | -4.94 Million EUR | 54.152% |
Euromedis Groupe | 13.11 Million EUR | 117.297% |
Eurobio Scientific Société anonyme | 4.83 Million EUR | 146.901% |
Implanet S.A. | -6.67 Million EUR | 66.033% |
Median Technologies SA | -22.98 Million EUR | 90.133% |
SpineGuard SA | -4.18 Million EUR | 45.794% |
Theraclion SA | -3.67 Million EUR | 38.295% |
Euroapi S.A. | -189.7 Million EUR | 98.805% |
Guerbet SA | 23.86 Million EUR | 109.502% |
Ion Beam Applications SA | -9.11 Million EUR | 75.108% |
Koninklijke Philips N.V. | -466 Million EUR | 99.513% |
Sequana Medical NV | -32.56 Million EUR | 93.036% |